Trials / Completed
CompletedNCT01732406
Acromegaly Treatment Quality of Life Study
Effect of Growth Hormone Receptor Antagonism and Somatostatin Analog Administration on Quality of Life
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 126 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that treatment of acromegaly will be associated with an improvement in quality of life compared to active acromegaly. At the same time, they will also be studying the effects of different acromegaly treatments on the quality of life.
Conditions
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-12-19
- Completion
- 2016-12-19
- First posted
- 2012-11-22
- Last updated
- 2019-04-29
- Results posted
- 2019-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01732406. Inclusion in this directory is not an endorsement.